Privia Health PE Ratio 2020-2023 | PRVA
Current and historical p/e ratio for Privia Health (PRVA) from 2020 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Privia Health PE ratio as of May 15, 2024 is 120.33.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Privia Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-15 | 17.37 | 91.42 | |
| 2023-12-31 | 23.03 | $0.19 | 121.21 |
| 2023-09-30 | 23.00 | $0.31 | 74.19 |
| 2023-06-30 | 26.11 | $0.27 | 96.70 |
| 2023-03-31 | 27.61 | $0.11 | 251.00 |
| 2022-12-31 | 22.71 | $-0.11 | 0.00 |
| 2022-09-30 | 34.06 | $-0.36 | 0.00 |
| 2022-06-30 | 29.12 | $-0.46 | 0.00 |
| 2022-03-31 | 26.73 | $-2.04 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.154B | $1.658B |
| Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.755B | 20.18 |
| Inspire Medical Systems (INSP) | United States | $4.712B | 0.00 |
| Axonics (AXNX) | United States | $3.441B | 0.00 |
| 10x Genomics (TXG) | United States | $3.165B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.092B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.951B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.949B | 0.00 |
| Enovis (ENOV) | United States | $2.880B | 21.34 |
| Azenta (AZTA) | United States | $2.763B | 155.30 |
| Schrodinger (SDGR) | United States | $1.690B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 48.06 |
| Phreesia (PHR) | United States | $1.251B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.668B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.643B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.505B | 0.00 |
| Talkspace (TALK) | United States | $0.484B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.404B | 0.00 |
| Pulmonx (LUNG) | United States | $0.346B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.303B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.212B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.207B | 0.00 |
| Outset Medical (OM) | United States | $0.181B | 0.00 |
| American Well (AMWL) | United States | $0.148B | 0.00 |
| TruBridge (TBRG) | United States | $0.132B | 7.10 |
| MSP Recovery (LIFW) | United States | $0.113B | 0.00 |
| 111 (YI) | China | $0.110B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.073B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.068B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.063B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.053B | 0.00 |
| Movano (MOVE) | United States | $0.041B | 0.00 |
| Akili (AKLI) | United States | $0.035B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| CareCloud (CCLD) | United States | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Syra Health (SYRA) | United States | $0.011B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |